MYGN
Myriad Genetics Inc.
Company Overview
| Mkt Cap | $756.45M | Price | $8.04 |
| Volume | 903.97K | Change | +1.13% |
| P/E Ratio | -5.9 | Open | $7.93 |
| Revenue | $837.6M | Prev Close | $7.95 |
| Net Income | $-127.3M | 52W Range | $3.76 - $19.60 |
| Div Yield | N/A | Target | $7.68 |
| Overall | 59 | Value | 60 |
| Quality | 42 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyMyriad Genetics Inc. (MYGN) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $8.04 with a market capitalization of $756.45 million. The stock is in the lower portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows MYGN with a volume of 904K shares. The stock opened down 0.25% from yesterday's close of $7.95. Current analyst estimates project earnings of $-0.4 per share for this year, with next year targeting $-0.3.
MYGN demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including BIO, EXAS, BIOC, BMRN, ABT.
Key investment considerations for MYGN include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -4.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:17 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MYGN | $8.04 | +1.1% | 903.97K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |